SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer
Crossref DOI link: https://doi.org/10.1007/s00066-016-0971-2
Published Online: 2016-05-25
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rucinska, Monika
Kieszkowska-Grudny, Anna
Nawrocki, Sergiusz
License valid from 2016-05-25